‌

US Patent 10240149 Reduced size self-delivering RNAi compounds

Patent 10240149 was granted and assigned to Phio Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Dmitry Samarsky0

Joanne Kamens0

Tod M. Woolf0

William Salomon0

James Cardia0

Anastasia Khvorova0

Date of Patent

March 26, 2019

Patent Application Number

14729006

Date Filed

June 2, 2015

Patent Citations

US Patent 10041073 Reduced size self-delivering RNAi compounds

0

Patent Citations Received

US Patent 11926828 Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1

0

US Patent 10934550 Immunotherapy of cancer

US Patent 11584933 RNA interference in ocular indications

US Patent 11001845 Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)

US Patent 11021707 Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA

0

US Patent 11254940 Inhibition of MAP4K4 through RNAi

US Patent 11648260 Vesicles comprising a PTEN inhibitor and uses of same

0

US Patent 11279934 Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

0

...

Patent Primary Examiner

Patent abstract

The present invention relates to methods for in vivo administration of sd-rxRNA molecules.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10240149 Reduced size self-delivering RNAi compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.